STUDY OF IMMUNOHISTOCHEMISTRY OF BREAST CANCER

Abstract

 The quantification of biomarkers on immunohistochemistry breast cancer images is essential for defining appropriate therapy for breast cancer patients as well as for extracting relevant information on disease prognosis. This is an arduous and time-consuming task that may introduce a bias in the results due to intra- and inter-observer variability which could be alleviated by making use of automatic quantification tools. However, this is not a simple processing task given the heterogeneity of breast tumors that results in non-uniformly distributed tumor cells exhibiting different staining colors and intensity, size, shape, and texture, of the nucleus, cytoplasm and membrane.

In this research work, we demonstrate the feasibility of using a deep learning-based instance segmentation architecture for the automatic quantification of both nuclear and membrane biomarkers applied to IHC-stained slides. We have solved the cumbersome task of training set generation with the design and implementation of a web platform, which has served as a hub for communication and feedback between researchers and pathologists as well as a system for the validation of the automatic image processing models. Through this tool, we have collected annotations over samples of HE, ER and Ki-67 (nuclear biomarkers) and HER2 (membrane biomarker) IHC-stained images. Using the same deep learning network architecture, we have trained two models, so-called nuclei- and membrane-aware segmentation models, which, once successfully validated, have revealed to be a promising method to segment nuclei instances in IHC-stained images. The quantification method proposed in this work has been integrated into the developed web platform and is currently being used as a decision-support tool by pathologists.